日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

SUSD2 suppresses CD8+ T cell antitumor immunity by targeting IL-2 receptor signaling

SUSD2 通过靶向 IL-2 受体信号抑制 CD8+ T 细胞抗肿瘤免疫

Bao Zhao, Weipeng Gong, Anjun Ma, Jianwen Chen, Maria Velegraki, Hong Dong, Zihao Liu, Lingling Wang, Tamio Okimoto, Devin M Jones, Yu L Lei, Meixiao Long, Kenneth J Oestreich, Qin Ma, Gang Xin, David P Carbone, Kai He, Zihai Li, Haitao Wen

An immunogold single extracellular vesicular RNA and protein (Au SERP) biochip to predict responses to immunotherapy in non-small cell lung cancer patients

免疫金单细胞外囊泡 RNA 和蛋白质 (Au SERP) 生物芯片用于预测非小细胞肺癌患者对免疫疗法的反应

Luong T H Nguyen, Jingjing Zhang, Xilal Y Rima, Xinyu Wang, Kwang Joo Kwak, Tamio Okimoto, Joseph Amann, Min Jin Yoon, Takehito Shukuya, Chi-Ling Chiang, Nicole Walters, Yifan Ma, Donald Belcher, Hong Li, Andre F Palmer, David P Carbone, L James Lee, Eduardo Reátegui

Metabolic reprogramming by adenosine antagonism and implications in non-small cell lung cancer therapy

腺苷拮抗代谢重编程及其对非小细胞肺癌治疗的影响

Shuxiao Guan, Shankar Suman, Joseph M Amann, Ruohan Wu, David P Carbone, Jie Wang, Mikhail M Dikov

STK11/LKB1 Loss of Function Is Associated with Global DNA Hypomethylation and S-Adenosyl-Methionine Depletion in Human Lung Adenocarcinoma

STK11/LKB1 功能丧失与人类肺腺癌中的全局 DNA 低甲基化和 S-腺苷甲硫氨酸耗竭有关

Michael J Koenig, Bernice A Agana, Jacob M Kaufman, Michael F Sharpnack, Walter Z Wang, Christoph Weigel, Fabio C P Navarro, Joseph M Amann, Nicole Cacciato, Rajeswara Rao Arasada, Mark B Gerstein, Vicki H Wysocki, Christopher Oakes, David P Carbone

Weighting tumor-specific TCR repertoires as a classifier to stratify the immunotherapy delivery in non-small cell lung cancers

以肿瘤特异性 TCR 库为权重,作为分类器对非小细胞肺癌的免疫治疗进行分层

Jiefei Han, Ruofei Yu, Jianchun Duan, Jin Li, Wei Zhao, Guoshuang Feng, Hua Bai, Yuqi Wang, Xue Zhang, Rui Wan, Jiachen Xu, Xin Wang, Yanfang Guan, Xuefeng Xia, Zhuoran Yao, Kailun Fei, David P Carbone, Zhijie Wang, Jie Wang

Predicting ROR1/BCL2 combination targeted therapy of small cell carcinoma of the lung

预测肺癌小细胞癌的ROR1/BCL2联合靶向治疗

Walter Z Wang, Konstantin Shilo, Joseph M Amann, Alyssa Shulman, Mohammad Hojjat-Farsangi, Håkan Mellstedt, Johan Schultz, Carlo M Croce, David P Carbone

Thrombin contributes to cancer immune evasion via proteolysis of platelet-bound GARP to activate LTGF-β

凝血酶通过蛋白水解作用水解血小板结合的GARP,激活LTGF-β,从而促进肿瘤免疫逃逸。

Alessandra Metelli ,Bill X Wu ,Brian Riesenberg ,Silvia Guglietta ,John D Huck ,Catherine Mills ,Anqi Li ,Saleh Rachidi ,Carsten Krieg ,Mark P Rubinstein ,Daniel T Gewirth ,Shaoli Sun ,Michael B Lilly ,Amy H Wahlquist ,David P Carbone ,Yiping Yang ,Bei Liu ,Zihai Li

Co-Expression Analysis Reveals Mechanisms Underlying the Varied Roles of NOTCH1 in NSCLC

共表达分析揭示 NOTCH1 在 NSCLC 中发挥不同作用的机制

Sara L Sinicropi-Yao, Joseph M Amann, David Lopez Y Lopez, Ferdinando Cerciello, Kevin R Coombes, David P Carbone

Adaptive Resistance to Dual BRAF/MEK Inhibition in BRAF-Driven Tumors through Autocrine FGFR Pathway Activation

通过自分泌 FGFR 通路激活,BRAF 驱动的肿瘤对 BRAF/MEK 双重抑制产生适应性抗性

Victoria E Wang, Jenny Y Xue, Dennie T Frederick, Yi Cao, Eva Lin, Catherine Wilson, Anatoly Urisman, David P Carbone, Keith T Flaherty, Rene Bernards, Piro Lito, Jeff Settleman, Frank McCormick

Histone Deacetylase Inhibition Enhances the Antitumor Activity of a MEK Inhibitor in Lung Cancer Cells Harboring RAS Mutations

组蛋白去乙酰化酶抑制可增强 MEK 抑制剂对携带 RAS 突变的肺癌细胞的抗肿瘤活性

Tadaaki Yamada, Joseph M Amann, Azusa Tanimoto, Hirokazu Taniguchi, Takehito Shukuya, Cynthia Timmers, Seiji Yano, Konstantin Shilo, David P Carbone